Bevacizumab for choroidal neovascularization secondary to age-related macular degeneration and pathological myopia (Q38256840)

From Wikidata
Jump to navigation Jump to search
scientific article published on 04 October 2014
edit
Language Label Description Also known as
English
Bevacizumab for choroidal neovascularization secondary to age-related macular degeneration and pathological myopia
scientific article published on 04 October 2014

    Statements

    Bevacizumab for choroidal neovascularization secondary to age-related macular degeneration and pathological myopia (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit